Table 2.
Complement Dependence of the Enhancement of Infarct Size by Human CRP
| Treatment | No. treated | Day 5 survivors | Infarct size mean (SD) | Bonferroni t test vs. controls |
|---|---|---|---|---|
| % | ||||
| Buffer only | 8 | 8 | 14.3 (1.2) | – |
| Human CRP | 5 | 3 | 19.7 (1.6) | P = 0.0020 |
| Complement | ||||
| depletion | 5 | 5 | 6.5 (0.9) | P = 0.0000 |
| Complement | ||||
| depletion + | ||||
| human CRP | 6 | 6 | 6.9 (0.3) | P = 0.0000 |
Human CRP at 40 mg/kg was injected intraperitoneally 1 h after coronary artery ligation and then at 24-h intervals until all rats were killed 5 d later; controls received buffer alone. Parallel groups had been decomplemented by intraperitoneal injection of cobra venom factor at 250 U/kg 24 h before coronary artery ligation.